Robert S Fishman - Net Worth and Insider Trading
Robert S Fishman Net Worth
The estimated net worth of Robert S Fishman is at least $0 dollars as of 2024-09-20. Robert S Fishman is the Chief Medical Officer of Corcept Therapeutics Inc and owns about 0 shares of Corcept Therapeutics Inc (CORT) stock worth over $0. Details can be seen in Robert S Fishman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert S Fishman has not made any transactions after 2018-11-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert S Fishman
Robert S Fishman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert S Fishman owns 2 companies in total, including Corcept Therapeutics Inc (CORT) , and 4D Molecular Therapeutics Inc (FDMT) .
Click here to see the complete history of Robert S Fishman’s form 4 insider trades.
Insider Ownership Summary of Robert S Fishman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2018-11-07 | 10 percent owner |
| FDMT | 4D Molecular Therapeutics Inc | 2020-12-10 | Chief Medical Officer |
Robert S Fishman Latest Holdings Summary
Robert S Fishman currently owns a total of 1 stock. Robert S Fishman owns 0 shares of Corcept Therapeutics Inc (CORT) as of November 7, 2018, with a value of $0.
Latest Holdings of Robert S Fishman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2018-11-07 | 0 | 42.25 | 0 |
Holding Weightings of Robert S Fishman
Robert S Fishman Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert S Fishman has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the sale of 8,000 shares on November 7, 2018, which brought Robert S Fishman around $109,920.
Insider Trading History of Robert S Fishman
- 1
Robert S Fishman Trading Performance
Robert S Fishman Ownership Network
Robert S Fishman Owned Company Details
What does Corcept Therapeutics Inc do?
Who are the key executives at Corcept Therapeutics Inc?
Robert S Fishman is the 10 percent owner of Corcept Therapeutics Inc. Other key executives at Corcept Therapeutics Inc include Chief Development Officer William Guyer , CHIEF FINANCIAL OFFICER Gary Charles Robb , and Chief Accounting Officer Joseph Douglas Lyon .
Corcept Therapeutics Inc (CORT) Insider Trades Summary
Over the past 18 months, Robert S Fishman made no insider transaction in Corcept Therapeutics Inc (CORT). Other recent insider transactions involving Corcept Therapeutics Inc (CORT) include a net sale of 70,000 shares made by Joseph Douglas Lyon , a net sale of 28,750 shares made by Swisher Daniel N Jr , and a net sale of 225,000 shares made by Sean Maduck .
In summary, during the past 3 months, insiders sold 51,451 shares of Corcept Therapeutics Inc (CORT) in total and bought 0 shares, with a net sale of 51,451 shares. During the past 18 months, 530,899 shares of Corcept Therapeutics Inc (CORT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 530,899 shares.
Corcept Therapeutics Inc (CORT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Corcept Therapeutics Inc Insider Transactions
Robert S Fishman Mailing Address
Above is the net worth, insider trading, and ownership report for Robert S Fishman. You might contact Robert S Fishman via mailing address: 2071 Stierlin Court, Mountain View Ca 94043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
